Olmesartan and Hydrochlorothiazide Interaction

Understanding the Olmesartan and Hydrochlorothiazide Interaction

FDA-approved prescribing information for these two drugs flags their combination as a moderate-severity interaction. Olmesartan belongs to the Angiotensin II Receptor Blocker (ARB) class and Hydrochlorothiazide belongs to the Thiazide Diuretic class - two categories that can collide when co-prescribed. The mechanism described in FDA labeling is: Both drugs work to lower blood pressure, which can increase the risk of your blood pressure dropping too low or your kidney function changing. Severity tiers matter: major flags generally advise avoidance, moderate flags often require monitoring or dose adjustment, and minor flags may only call for awareness.

Context around a specific patient determines real-world impact. Olmesartan has 7 total documented interactions on file in this dataset, and Hydrochlorothiazide has 31. Each additional medication compounds the interaction surface, which is why pharmacists run full-profile checks rather than evaluating one pair at a time. FDA-derived guidance for this pair is: Your doctor should monitor your blood pressure and kidney health regularly while you are taking this combination. Timing of doses, renal and hepatic function, age, and other concurrent prescriptions all shape whether a labeled interaction matters clinically.

An interaction flag is not a verdict. A large share of labeled interactions are managed routinely in clinical practice, the fix may be as simple as spacing doses or adding a monitoring test. Others require the prescriber to choose a different medication entirely. This page surfaces FDA-sourced labeling and openFDA data for educational purposes only; it is not medical advice and cannot account for your full clinical picture. Never start, stop, or adjust either Olmesartan or Hydrochlorothiazide based on a web page, speak with your prescriber or pharmacist before making any change.